Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections
In certain aspects, the invention relates to methods of treating proliferative cervical disorders (such as cervical cancer and cervical dysplasia) and treating virus infections by administering artemisinin-related compounds. In certain aspects, the invention relates to methods of treating a tumor induced by an oncogenic virus, methods of killing or inhibiting a squamous cell carcinoma, and methods of inhibiting the replication of a virus, by administering artemisinin-related compounds.
1. A method of treating an HPV-induced condition in a human subject, wherein the condition is cervical dysplasia, cervical cancer or both, the method comprising:
identifying a subject with cervical cancer, cervical dysplasia or both, and
administering a therapeutically effective amount of an artemisinin-related compound to the identified subject, wherein the artemisinin-related compound is artemisinin, dihydroartemisinin, artemether, arteether, artesunate, artelinic acid, dihydroartemisinin propyl carbonate, or any combination thereof, and
wherein the artemisinin-related compound is administered to the identified human subject by oral administration, topical administration, parenteral administration, intravaginal administration, rectal administration, systemical administration, intramuscular administration, or intravenous administration.
2. The method of claim 1 , wherein artesunate is administered to the identified subject.
3. The method of claim 1 wherein artemisinin is administered to the identified subject.
4. The method of claim 1 , wherein the artemisinin-related compound is administered to the identified human subject by topical administration.
5. The method of claim 4 , wherein the artemisinin-related compound is administered to a mucosal membrane of the identified subject.
6. The method of claim 4 , wherein artesunate is administered to the identified subject.
7. The method of claim 4 , wherein artemisinin is administered to the identified subject.
8. The method of claim 1 , wherein the artemisinin-related compound is administered with an anti-viral agent.
9. The method of claim 8 , wherein the artemisinin-related compound and the anti-viral agent are in the same formulation.
10. The method of claim 1 , wherein the artemisinin-related compound is administered with an anti-cancer agent to the identified subject.
11. The method of claim 10 , wherein the artemisinin-related compound and the anti-cancer agent are in the same formulation.